← Leaderboards
Alice M. Clark
University Of Mississippi
$4,666,208
Attributed
$4,666,208
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $435.1K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$4,666,208 · 2
By mechanism
R01$4,666,208 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Mississippi
Same institution · by research overlap
- Ameeta Kishore Agarwal$405,330
- Mark T Hamann$5,667,987
Others in their field
Top investigators on “Antifungal Agents”
- Arturo Casadevall · Johns Hopkins University$18,526,841
- Bruce Steven Klein · University Of Wisconsin-Madison$17,392,738
- Susanna Naggie · Duke University$17,352,697
- Joseph Heitman · Duke University$16,390,121
- Robert Andrew Cramer · Sloan-Kettering Inst Can Research$14,663,188
- Gavin J Sherlock · Stanford University$14,134,024
Research focus
Antifungal AgentsOpportunistic InfectionsDrug DiscoveryMolecular TargetPharmaceutical PreparationsMycosesGenomicsDrug Screening /EvaluationAreaPathogenDrug Design /Synthesis /ProductionBiologyPrototypeResistanceAids Related CancerLeadFoundationsFuturePathway InteractionsCandidaPlant ExtractsMycosisDrug Discovery /IsolationCancer Patient
Grant awards (16)
New Drugs for Opportunistic Infections$375,897
R01 · FY2013 · AI · contact PI
New Drugs for Opportunistic Infections$392,035
R01 · FY2012 · AI · contact PI
New Drugs for Opportunistic Infections$384,375
R01 · FY2011 · AI · contact PI
New Drugs for Opportunistic Infections$388,221
R01 · FY2010 · AI · contact PI
New Drugs for Opportunistic Infections$46,910
R01 · FY2010 · AI · contact PI
New Drugs for Opportunistic Infections$361,649
R01 · FY2009 · AI · contact PI
New Drugs for Opportunistic Infections$300,328
R01 · FY2008 · AI · contact PI
New Drugs for Opportunistic Infections$303,465
R01 · FY2007 · AI · contact PI
New Drugs for Opportunistic Infections$309,825
R01 · FY2006 · AI · contact PI
New Drugs for Opportunistic Infections$314,593
R01 · FY2005 · AI
New Drugs for Opportunistic Infections$287,000
R01 · FY2004 · AI
NEW DRUGS FOR OPPORTUNISTIC INFECTIOUS DISEASES$251,125
R01 · FY2003 · AI
NEW DRUGS FOR OPPORTUNISTIC INFECTIOUS DISEASES$251,125
R01 · FY2002 · AI
NEW DRUGS FOR OPPORTUNISTIC INFECTIOUS DISEASES$215,250
R01 · FY2001 · AI
CANDIDA SECRETED ASPARTIC PROTEASES AS DRUG TARGETS$268,410
R01 · FY2000 · AI
NEW DRUGS FOR OPPORTUNISTIC INFECTIOUS DISEASES$216,000
R01 · FY2000 · AI